Rafael (NYSE:RFL - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Sunday.
Rafael Trading Down 2.4%
NYSE:RFL opened at $1.64 on Friday. The business's 50-day moving average is $1.90 and its 200 day moving average is $1.81. Rafael has a 12 month low of $1.28 and a 12 month high of $3.19. The company has a market capitalization of $57.51 million, a P/E ratio of -1.74 and a beta of 0.99.
Rafael (NYSE:RFL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The company reported ($0.19) earnings per share for the quarter. Rafael had a negative return on equity of 24.75% and a negative net margin of 3,127.60%. The company had revenue of $0.36 million for the quarter.
Insiders Place Their Bets
In other Rafael news, CEO Howard S. Jonas bought 13,080,457 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $1.28 per share, with a total value of $16,742,984.96. Following the completion of the purchase, the chief executive officer owned 12,299,207 shares in the company, valued at $15,742,984.96. This represents a -1,674.30% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 10.20% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of RFL. Wealth Enhancement Advisory Services LLC bought a new position in shares of Rafael during the first quarter valued at approximately $26,000. Simplex Trading LLC bought a new position in Rafael in the second quarter worth approximately $32,000. Americana Partners LLC bought a new position in Rafael in the second quarter worth approximately $76,000. Geode Capital Management LLC lifted its holdings in Rafael by 17.9% during the fourth quarter. Geode Capital Management LLC now owns 174,561 shares of the company's stock worth $288,000 after buying an additional 26,493 shares during the period. Finally, Ieq Capital LLC purchased a new stake in Rafael during the first quarter worth $447,000. Institutional investors own 11.30% of the company's stock.
Rafael Company Profile
(
Get Free Report)
Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rafael, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rafael wasn't on the list.
While Rafael currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access Sale